July 12th – GHLF testimony and recommendation to FDA on proposed biosimilar to HUMIRA (adalimumab)
7/
15
July 12th – GHLF testimony and recommendation to FDA on proposed biosimilar to HUMIRA (adalimumab)
Click here to listen to Seth’s Testimony